Skip to main content

Table 6 Correlation between clinical, laboratory profile, and electrodiagnostic findings of the patients

From: Quantitative motor unit potential analysis and nerve conduction studies for detection of subclinical peripheral nerve dysfunction in patients with compensated liver cirrhosis

   NESS RULNML LULNMC LULNSL LULNSC LULNSA LPERMC RFDID RFDIP LEHLD LEHLP
Age r .308* 0.202 − 0.148 0.225 − 0.239 − .310* − .340* − 0.101 .337* 0.014 .283*
P 0.03 0.160 0.306 0.116 0.095 0.029 0.016 0.488 0.018 0.921 0.047
n 50 50 50 50 50 50 50 49 49 50 50
Albumin r − .440** − .372** .418** − .381** .374** 0.203 .442** − .344* − 0.255 0.004 − 0.141
P 0.001 0.008 0.002 0.006 0.007 0.157 0.001 0.015 0.077 0.980 0.328
n 50 50 50 50 50 50 50 49 49 50 50
Bilirubin r − 0.057 − 0.008 0.046 − 0.164 0.249 0.178 0.058 0.103 0.013 0.087 − 0.086
P 0.693 0.958 0.750 0.256 0.081 0.217 0.690 0.483 0.929 0.547 0.553
n 50 50 50 50 50 50 50 49 49 50 50
Platelets r − .280* − 0.121 .343* 0.041 0.051 0.245 .282* − 0.125 − 0.023 0.074 − 0.101
P 0.049 0.401 0.015 0.778 0.726 0.086 0.047 0.393 0.876 0.609 0.487
n 50 50 50 50 50 50 50 49 49 50 50
Child score r .309* 0.123 − 0.177 0.053 − 0.099 − 0.100 − .282* 0.200 0.232 − 0.158 0.127
P 0.029 0.394 0.219 0.716 0.493 0.490 0.048 0.167 0.109 0.273 0.381
n 50 50 50 50 50 50 50 49 49 50 50
ALBI score r − .339* − .318* .383** − 0.251 .281* 0.142 .354* − 0.187 − 0.152 0.023 − 0.177
P 0.016 0.024 0.006 0.079 0.048 0.325 0.012 0.198 0.296 0.874 0.220
n 50 50 50 50 50 50 50 49 49 50 50
  1. NESS, neuropathy electrodiagnostic severity score; RULNML, right ulnar motor latency; LULNMC, left ulnar motor conduction velocity; LULNSL, left ulnar sensory latency; LULNSC, left ulnar sensory conduction velocity; LULNSA, left ulnar sensory amplitude; LPERMC, left peroneal motor conduction velocity; RFDID, right first dorsal interosseous duration, RFDIP, right first dorsal interosseous phases; LEHLD, left extensor hallucis longus duration; LEHLP, left extensor hallucis longus phases; ALT, alanine transaminase; AST, aspartate; INR, international normalized ratio; BMI, body mass index; NSC, neuropathy symptom and change; ALBI, albumin-bilirubin; r, correlation coefficient
  2. * Correlation is significant at the 0.05 level, ** Correlation is significant at the 0.01 level